Post-approval studies (Phase 4)Study completedNCT03610022
What this trial is testing
Relationship Between Pharmacokinetics and Safety of Vismodegib - OPTIVISMO-1
Who this might be right for
Metastatic Basal Cell CarcinomaLocally Advanced Basal Cell Carcinoma
University Hospital, Bordeaux 27